Pfizer\s Nirmatrelvir/ritonavir no relation healthcare in Israel
Medical response
As late as 15 March, doctors complained that guidelines for testing were too restrictive. On 16 March, the Health Ministry approved a number of experimental treatments for patients with COVID-19. On 18 March, the Defense Ministry took over purchasing of Corona-related gear. On the same day, the Israel Institute for Biological Research announced that they are working on a COVID-19 vaccine. On 18 March at 6 pm, Israelis across the country applauded from their balconies for two minutes in appreciation of medical workers and first responders battling coronavirus. On 29 March, Magen David Adom announced that it will collect blood plasma from recovered COVID-19 patients to treat those most severely affected by the infection. In December 2021, the Israeli Ministry of Health approved the use of Pfizer's Nirmatrelvir/ritonavir for treating COVID-19.
no relation